Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII
Lu Lu,1 Yue Ding,2 Yong Zhang,2 Rodney JY Ho,3 Yuan Zhao,4 Tong Zhang,1 Chunrong Guo2 1School of Pharmacy, 2Experiment Center for Teaching and Learning, Shanghai University of Traditional Chinese Medicine, Shanghai, China; 3Department of Pharmaceutics, University of Washington, Seattle, WA, USA; 4C...
Saved in:
Main Authors: | Lu L, Ding Yue, Zhang Y, Ho RJY, Zhao Y, Zhang T, Guo C |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/8d06d0ccec064df6a0466efd19e67947 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel Timosaponin AIII-Based Multifunctional Liposomal Delivery System for Synergistic Therapy Against Hepatocellular Carcinoma Cancer
by: Zhang L, et al.
Published: (2021) -
Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity
by: Han B, et al.
Published: (2020) -
In vitro comparison of liposomal drug delivery systems targeting the oxytocin receptor: a potential novel treatment for obstetric complications
by: Hua S, et al.
Published: (2019) -
Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome–Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes
by: Petrini M, et al.
Published: (2021) -
In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin
by: Ashrafzadeh MS, et al.
Published: (2020)